Stryker

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Stryker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. 

CEO
Kevin A. Lobo
CEOKevin A. Lobo
Employees
56,000
Employees56,000
Headquarters
Portage, Michigan
HeadquartersPortage, Michigan
Founded
1941
Founded1941
Employees
56,000
Employees56,000

SYK Key Statistics

Market cap
107.37B
Market cap107.37B
Price-Earnings ratio
29.55
Price-Earnings ratio29.55
Dividend yield
1.23%
Dividend yield1.23%
Average volume
2.57M
Average volume2.57M
High today
$285.86
High today$285.86
Low today
$272.99
Low today$272.99
Open price
$279.51
Open price$279.51
Volume
1.69M
Volume1.69M
52 Week high
$392.55
52 Week high$392.55
52 Week low
$267.00
52 Week low$267.00

Stock Snapshot

As of today, Stryker(SYK) shares are valued at $279.92. The company's market cap stands at 107.37B, with a P/E ratio of 29.55 and a dividend yield of 1.23%.

On 2026-10-06, Stryker(SYK) stock moved within a range of $272.99 to $285.86. With shares now at $279.92, the stock is trading +2.5% above its intraday low and -2.1% below the session's peak.

Trading activity shows a volume of 1.69M, compared to an average daily volume of 2.57M.

Over the past 52 weeks, Stryker(SYK) stock has traded between a high of $392.55 and a low of $267.00.

Over the past 52 weeks, Stryker(SYK) stock has traded between a high of $392.55 and a low of $267.00.

SYK News

Investing.com 55m
Truist cuts Stryker stock price target on revised forecasts - Investing.com

...

Truist cuts Stryker stock price target on revised forecasts - Investing.com
TipRanks 2h
Stryker price target lowered to $310 from $340 at Truist

Truist lowered the firm’s price target on Stryker (SYK) to $310 from $340 and keeps a Hold rating on the shares. Stryker’s CEO transition to Spencer Stiles is e...

Investor's Business Daily 5h
Stryker, Neogenomics Announce CEO Transitions; But One Stock Dives

Technology Stryker, Neogenomics Announce CEO Transitions; But One Stock Dives Licensing Stryker (SYK) and Neogenomics (NEO) stocks diverged Tuesday after the me...

Stryker, Neogenomics Announce CEO Transitions; But One Stock Dives

Analyst ratings

83%

of 30 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

More SYK News

TipRanks 6h
Stryker Announces CEO Succession and Leadership Transition

Stryker ( (SYK) ) has issued an update. On October 6, 2026, Stryker announced a planned leadership succession in which long-serving Chief Executive Officer Kev...

TipRanks 7h
Stryker CEO Kevin Lobo to transition to chair role, Spencer Stiles to succeed

Stryker (SYK) announced that as part of a planned succession process, Kevin Lobo will transition to the role of executive chair of the board of directors, effec...

Simply Wall St 9h
Stryker Stock Looks Discounted As Shares Fell 21%

has been under pressure after a sharp share price pullback and fresh headlines about extended manufacturing problems, which puts a spotlight on whether the curr...

Stryker Stock Looks Discounted As Shares Fell 21%

People also own

Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.